These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6333565)

  • 1. Demonstration and characterization of virus released by murine B cell leukemia cells (BCL1).
    Morecki S; Slavin S; Weiss L; Weigensberg M; Friedman A; Kotler M
    Leuk Res; 1984; 8(5):821-32. PubMed ID: 6333565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure.
    Muirhead MJ; Holbert JM; Uhr JW; Vitetta ES
    Am J Pathol; 1981 Dec; 105(3):306-15. PubMed ID: 6976124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural, cell membrane, and cytogenetic characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia.
    Slavin S; Weiss L; Morecki S; Bassat HB; Leizerowitz R; Gamliel H; Korkesh A; Voss R; Polliack A
    Cancer Res; 1981 Oct; 41(10):4162-6. PubMed ID: 6974594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution.
    Muirhead MJ; Isakson PC; Krolick KA; Uhr JW; Vitetta ES
    Am J Pathol; 1981 Dec; 105(3):295-305. PubMed ID: 7032308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1).
    Slavin S; Morecki S; Weiss L
    J Immunol; 1980 Feb; 124(2):586-9. PubMed ID: 6965384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation.
    Mumcuoglu M; Weiss L; Spivak J; Slavin S
    Bone Marrow Transplant; 1989 Mar; 4(2):143-6. PubMed ID: 2650782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
    Ciavarra R; Forman J
    J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody.
    Krolick KA; Isakson PC; Uhr JW; Vitetta ES
    J Immunol; 1979 Nov; 123(5):1928-35. PubMed ID: 385772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
    J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative response of murine B-cell leukemia (BCL1) to poly(L-lysine).
    Morecki S; Flechner Y; Slavin S
    Cell Immunol; 1985 Feb; 90(2):392-400. PubMed ID: 3871370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiotypic vaccination as a treatment for a B cell lymphoma.
    George AJ; Folkard SG; Hamblin TJ; Stevenson FK
    J Immunol; 1988 Sep; 141(6):2168-74. PubMed ID: 3049800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic analysis of the spontaneous murine B-cell leukemia (BCL1).
    Voss R; Maftzir G; Slavin S
    Leuk Res; 1980; 4(3):325-32. PubMed ID: 6968009
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of recombinant human manganese superoxide dismutase on radiosensitivity of murine B cell leukemia (BCL1) cells.
    Weiss L; Stern S; Reich S; Slavin S
    Leuk Lymphoma; 1993 Aug; 10(6):477-81. PubMed ID: 8401183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
    Weiss L; Morecki S; Vitetta ES; Slavin S
    J Immunol; 1983 May; 130(5):2452-5. PubMed ID: 6339628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.
    Knapp MR; Severinson-Gronowicz E; Schröder J; Strober S
    J Immunol; 1979 Sep; 123(3):1000-6. PubMed ID: 381513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1).
    Morecki S; Nagler A; Zakay-Rones Z; Schlesinger M; Lubina-Salomon A; Pugatsch T; Moshel Y; Slavin S
    Leuk Res; 1998 Sep; 22(9):831-5. PubMed ID: 9716015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.